Selected research
Industry Research
Hydroxychloroquine Drug Industry Research Report 2026
Market perspective
The global Hydroxychloroquine Drug market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Hydroxychloroquine Drug is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Hydroxychloroquine Drug is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Hydroxychloroquine Drug is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Hydroxychloroquine Drug include Teva Pharmaceutical, Sanofi, Novartis, Mylan, Zydus Cadila, Sun Pharmaceutical, Prasco Laboratories, Lupin Limited and Dr. Reddy’s Laboratories, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Hydroxychloroquine Drug market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Hydroxychloroquine Drug Market by Company
Teva Pharmaceutical
Sanofi
Novartis
Mylan
Zydus Cadila
Sun Pharmaceutical
Prasco Laboratories
Lupin Limited
Dr. Reddy’s Laboratories
Amneal Pharmaceuticals
Hydroxychloroquine Drug Segment by Type
COVID-19
Systemic Lupus Erythematosus
Malaria
Rheumatoid Arthritis
Others
Hydroxychloroquine Drug Segment by Application
Retail Pharmacies
Online Pharmacies
Hospital Pharmacies
Hydroxychloroquine Drug Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Hydroxychloroquine Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Hydroxychloroquine Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Hydroxychloroquine Drug.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Hydroxychloroquine Drug manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Hydroxychloroquine Drug by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Hydroxychloroquine Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- COVID-19
- Systemic Lupus Erythematosus
- Malaria
- Rheumatoid Arthritis
- Others
Applications
- Retail Pharmacies
- Online Pharmacies
- Hospital Pharmacies
Companies covered
- Teva Pharmaceutical
- Sanofi
- Novartis
- Mylan
- Zydus Cadila
- Sun Pharmaceutical
- Prasco Laboratories
- Lupin Limited
- Dr. Reddy’s Laboratories
- Amneal Pharmaceuticals
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Hydroxychloroquine Drug Market Size (2021-2032)
- 2.2.2 Global Hydroxychloroquine Drug Sales (2021-2032)
- 2.2.3 Global Hydroxychloroquine Drug Market Average Price (2021-2032)
- 2.3 Hydroxychloroquine Drug by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 COVID-19
- 2.3.3 Systemic Lupus Erythematosus
- 2.3.4 Malaria
- 2.3.5 Rheumatoid Arthritis
- 2.3.6 Others
- 2.4 Hydroxychloroquine Drug by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Retail Pharmacies
- 2.4.3 Online Pharmacies
- 2.4.4 Hospital Pharmacies
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Hydroxychloroquine Drug Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Hydroxychloroquine Drug Sales (K Units) of Manufacturers (2021-2026)
- 3.3 Global Hydroxychloroquine Drug Revenue of Manufacturers (2021-2026)
- 3.4 Global Hydroxychloroquine Drug Average Price by Manufacturers (2021-2026)
- 3.5 Global Hydroxychloroquine Drug Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Hydroxychloroquine Drug, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Hydroxychloroquine Drug, Product Type & Application
- 3.8 Global Manufacturers of Hydroxychloroquine Drug, Established Date
- 3.9 Global Hydroxychloroquine Drug Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Teva Pharmaceutical
- 4.1.1 Teva Pharmaceutical Company Information
- 4.1.2 Teva Pharmaceutical Business Overview
- 4.1.3 Teva Pharmaceutical Hydroxychloroquine Drug Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Teva Pharmaceutical Hydroxychloroquine Drug Product Portfolio
- 4.1.5 Teva Pharmaceutical Recent Developments
- 4.2 Sanofi
- 4.2.1 Sanofi Company Information
- 4.2.2 Sanofi Business Overview
- 4.2.3 Sanofi Hydroxychloroquine Drug Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Sanofi Hydroxychloroquine Drug Product Portfolio
- 4.2.5 Sanofi Recent Developments
- 4.3 Novartis
- 4.3.1 Novartis Company Information
- 4.3.2 Novartis Business Overview
- 4.3.3 Novartis Hydroxychloroquine Drug Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Novartis Hydroxychloroquine Drug Product Portfolio
- 4.3.5 Novartis Recent Developments
- 4.4 Mylan
- 4.4.1 Mylan Company Information
- 4.4.2 Mylan Business Overview
- 4.4.3 Mylan Hydroxychloroquine Drug Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Mylan Hydroxychloroquine Drug Product Portfolio
- 4.4.5 Mylan Recent Developments
- 4.5 Zydus Cadila
- 4.5.1 Zydus Cadila Company Information
- 4.5.2 Zydus Cadila Business Overview
- 4.5.3 Zydus Cadila Hydroxychloroquine Drug Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Zydus Cadila Hydroxychloroquine Drug Product Portfolio
- 4.5.5 Zydus Cadila Recent Developments
- 4.6 Sun Pharmaceutical
- 4.6.1 Sun Pharmaceutical Company Information
- 4.6.2 Sun Pharmaceutical Business Overview
- 4.6.3 Sun Pharmaceutical Hydroxychloroquine Drug Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Sun Pharmaceutical Hydroxychloroquine Drug Product Portfolio
- 4.6.5 Sun Pharmaceutical Recent Developments
- 4.7 Prasco Laboratories
- 4.7.1 Prasco Laboratories Company Information
- 4.7.2 Prasco Laboratories Business Overview
- 4.7.3 Prasco Laboratories Hydroxychloroquine Drug Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Prasco Laboratories Hydroxychloroquine Drug Product Portfolio
- 4.7.5 Prasco Laboratories Recent Developments
- 4.8 Lupin Limited
- 4.8.1 Lupin Limited Company Information
- 4.8.2 Lupin Limited Business Overview
- 4.8.3 Lupin Limited Hydroxychloroquine Drug Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Lupin Limited Hydroxychloroquine Drug Product Portfolio
- 4.8.5 Lupin Limited Recent Developments
- 4.9 Dr. Reddy’s Laboratories
- 4.9.1 Dr. Reddy’s Laboratories Company Information
- 4.9.2 Dr. Reddy’s Laboratories Business Overview
- 4.9.3 Dr. Reddy’s Laboratories Hydroxychloroquine Drug Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Dr. Reddy’s Laboratories Hydroxychloroquine Drug Product Portfolio
- 4.9.5 Dr. Reddy’s Laboratories Recent Developments
- 4.10 Amneal Pharmaceuticals
- 4.10.1 Amneal Pharmaceuticals Company Information
- 4.10.2 Amneal Pharmaceuticals Business Overview
- 4.10.3 Amneal Pharmaceuticals Hydroxychloroquine Drug Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Amneal Pharmaceuticals Hydroxychloroquine Drug Product Portfolio
- 4.10.5 Amneal Pharmaceuticals Recent Developments
5 Global Hydroxychloroquine Drug Market Scenario by Region
- 5.1 Global Hydroxychloroquine Drug Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Hydroxychloroquine Drug Sales by Region: 2021-2032
- 5.2.1 Global Hydroxychloroquine Drug Sales by Region: 2021-2026
- 5.2.2 Global Hydroxychloroquine Drug Sales by Region: 2027-2032
- 5.3 Global Hydroxychloroquine Drug Revenue by Region: 2021-2032
- 5.3.1 Global Hydroxychloroquine Drug Revenue by Region: 2021-2026
- 5.3.2 Global Hydroxychloroquine Drug Revenue by Region: 2027-2032
- 5.4 North America Hydroxychloroquine Drug Market Facts & Figures by Country
- 5.4.1 North America Hydroxychloroquine Drug Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Hydroxychloroquine Drug Sales by Country (2021-2032)
- 5.4.3 North America Hydroxychloroquine Drug Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.5 Europe Hydroxychloroquine Drug Market Facts & Figures by Country
- 5.5.1 Europe Hydroxychloroquine Drug Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Hydroxychloroquine Drug Sales by Country (2021-2032)
- 5.5.3 Europe Hydroxychloroquine Drug Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Netherlands
- 5.5.9 Nordic Countries
- 5.6 Asia Pacific Hydroxychloroquine Drug Market Facts & Figures by Country
- 5.6.1 Asia Pacific Hydroxychloroquine Drug Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Hydroxychloroquine Drug Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Hydroxychloroquine Drug Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 China Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Hydroxychloroquine Drug Market Facts & Figures by Country
- 5.7.1 South America Hydroxychloroquine Drug Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Hydroxychloroquine Drug Sales by Country (2021-2032)
- 5.7.3 South America Hydroxychloroquine Drug Revenue by Country (2021-2032)
- 5.7.4 Mexico
- 5.7.5 Brazil
- 5.7.6 Argentina
- 5.8 Middle East and Africa Hydroxychloroquine Drug Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Hydroxychloroquine Drug Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Hydroxychloroquine Drug Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Hydroxychloroquine Drug Revenue by Country (2021-2032)
- 5.8.4 Turkey
- 5.8.5 Saudi Arabia
- 5.8.6 UAE
6 Segment by Type
- 6.1 Global Hydroxychloroquine Drug Sales by Type (2021-2032)
- 6.1.1 Global Hydroxychloroquine Drug Sales by Type (2021-2032) & (K Units)
- 6.1.2 Global Hydroxychloroquine Drug Sales Market Share by Type (2021-2032)
- 6.2 Global Hydroxychloroquine Drug Revenue by Type (2021-2032)
- 6.2.1 Global Hydroxychloroquine Drug Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Hydroxychloroquine Drug Revenue Market Share by Type (2021-2032)
- 6.3 Global Hydroxychloroquine Drug Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Hydroxychloroquine Drug Sales by Application (2021-2032)
- 7.1.1 Global Hydroxychloroquine Drug Sales by Application (2021-2032) & (K Units)
- 7.1.2 Global Hydroxychloroquine Drug Sales Market Share by Application (2021-2032)
- 7.2 Global Hydroxychloroquine Drug Revenue by Application (2021-2032)
- 7.2.1 Global Hydroxychloroquine Drug Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Hydroxychloroquine Drug Revenue Market Share by Application (2021-2032)
- 7.3 Global Hydroxychloroquine Drug Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Hydroxychloroquine Drug Value Chain Analysis
- 8.1.1 Hydroxychloroquine Drug Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Hydroxychloroquine Drug Production Mode & Process
- 8.2 Hydroxychloroquine Drug Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Hydroxychloroquine Drug Distributors
- 8.2.3 Hydroxychloroquine Drug Customers
9 Global Hydroxychloroquine Drug Analyzing Market Dynamics
- 9.1 Hydroxychloroquine Drug Industry Trends
- 9.2 Hydroxychloroquine Drug Industry Drivers
- 9.3 Hydroxychloroquine Drug Industry Opportunities and Challenges
- 9.4 Hydroxychloroquine Drug Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst